Virpax Pharmaceuticals, Inc.
VRPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,513 | $9,142 | $18,995 | $36,842 |
| Short-Term Investments | $1,511,544 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $42,557 | $487 | $678 | $2,730 |
| Total Curr. Assets | $1,555,614 | $9,628 | $19,674 | $39,572 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,555,614 | $9,628 | $19,674 | $39,572 |
| Liabilities | – | – | – | – |
| Payables | $0 | $18 | $38 | $20 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $8 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,469,374 | $7,676 | $3,057 | $2,060 |
| Total Curr. Liab. | $2,469,374 | $7,694 | $3,095 | $2,088 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $1 | $0 |
| Other Liabilities | $0 | $0 | -$1 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,469,374 | $7,694 | $3,095 | $2,088 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$71,611,360 | -$59,544 | -$44,355 | -$22,704 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $70,697,600 | $61,478 | $60,934 | $60,189 |
| Total Equity | -$913,760 | $1,934 | $16,579 | $37,485 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,555,614 | $9,628 | $19,674 | $39,572 |
| Net Debt | -$1,513 | -$9,142 | -$18,995 | -$36,842 |